LH Stock Summary and Trading Ideas (Labcorp Holdings | NYSE:LH)

Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.

Labcorp Holdings trades on the NYSE stock market under the symbol LH.

As of March 6, 2026, LH stock price declined to $269.67 with 463,549 million shares trading.

LH has a beta of 0.35, meaning it tends to be less sensitive to market movements. LH has a correlation of 0.06 to the broad based SPY ETF.

LH has a market cap of $22.38 billion. This is considered a Large Cap stock.

Last quarter Labcorp Holdings reported $4 billion in Revenue and $4.07 earnings per share. This fell short of revenue expectation by $-40 million and exceeded earnings estimates by $.12.

In the last 3 years, LH traded as high as $293.72 and as low as $191.97.

The top ETF exchange traded funds that LH belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.

LH has underperformed the market in the last year with a price return of +7.2% while the SPY ETF gained +16.6%. However, in the short term, LH had mixed performance relative to the market. It has outperformed in the last 3 months, returning +4.6% vs -1.7% return in SPY. But in the last 2 weeks, LH shares have been beat by the market, returning -4.3% compared to an SPY return of -1.8%.

LH support price is $271.23 and resistance is $280.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LH shares will trade within this expected range on the day.